Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4565 USD | -1.36% | -3.83% | -68.73% |
05-06 | Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib | MT |
05-06 | RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
-68.73% | 14.55M | |
-2.95% | 90.75B | |
-1.97% | 39.03B | |
-15.47% | 31.85B | |
+60.52% | 26.26B | |
-22.81% | 14.13B | |
-8.82% | 12.87B | |
-11.77% | 11.6B | |
-45.97% | 10.91B | |
+3.00% | 8.89B |
- Stock Market
- Equities
- RDHL Stock
- News RedHill Biopharma Ltd.
- Transcript : RedHill Biopharma Ltd., Q1 2020 Earnings Call, May 27, 2020